The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of Washington's demand for confidential information.
This rejection became public following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government representative later clarified that the United States was demanding access to health data for research and profit while was not willing to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more negotiations to find a agreement suitable to all parties so the country's vital HIV treatment initiative can proceed.
Wider Context
This development follows a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the safety of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.
As per reports, Sixteen African countries have to date agreed to these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our population if a future health crisis arise."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were disrupting frameworks previously established via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This system is intended to ensure that when a nation contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome continued dialogue with our US partners on how future collaboration might be designed in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
A leading public health body stated it understood the government's concerns, but suggested that negotiations should continue considering a large portion of the country's Aids initiatives were funded by international support.
"If technical issues exist, such as those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.
This impasse emphasises the complex tensions between receiving crucial international aid and protecting local interests in an increasingly data-driven world.